Drug Price Hike Row: Pharma Companies Upset with Minimal Increase

  • Indian pharmaceutical companies are expressing discontent over a minimal price hike allowed for essential medicines in FY25.
  • The National Pharmaceutical Pricing Authority (NPPA) recently approved a negligible increase of only 0.00551% for drugs on the National List of Essential Medicines (NLEM).
  • Pharma companies argue that this minimal increase doesn't account for rising input costs, squeezing profit margins and hindering investments in research and development.
  • The industry has faced several years of low single-digit price increases for NLEM drugs, adding to their concerns.
  • This development could potentially impact the availability and affordability of essential medicines in India.

Comments

Popular posts from this blog

Gaming Industry Bigger Than Film & Music Combined

Major Changes In Physical Education Syllabus For Class 12 2023-2024!